Adipocyte Dynamics and Reversible Metabolic Syndrome in Mice with an Inducible Adipocyte-Specific Deletion of the Insulin Receptor

Cell Metab. 2017 Feb 7;25(2):448-462. doi: 10.1016/j.cmet.2016.12.008. Epub 2017 Jan 5.

Abstract

Insulin and IGF1 signaling are important for adipose tissue development and function; however, their role in mature adipocytes is unclear. Mice with a tamoxifen-inducible knockout of insulin and/or IGF1 receptors (IR/IGF1R) demonstrate a rapid loss of white and brown fat due to increased lipolysis and adipocyte apoptosis. This results in insulin resistance, glucose intolerance, hepatosteatosis, islet hyperplasia with hyperinsulinemia, and cold intolerance. This phenotype, however, resolves over 10-30 days due to a proliferation of preadipocytes and rapid regeneration of both brown and white adipocytes as identified by mTmG lineage tracing. This cycle can be repeated with a second round of receptor inactivation. Leptin administration prior to tamoxifen treatment blocks development of the metabolic syndrome without affecting adipocyte loss or regeneration. Thus, IR is critical in adipocyte maintenance, and this loss of adipose tissue stimulates regeneration of brown/white fat and reversal of metabolic syndrome associated with fat loss.

Keywords: adipocyte regeneration; adipogenesis; brown adipocyte; fatty liver; insulin action; insulin receptor knockout; insulin resistance; leptin; lineage tracing; β cell proliferation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adipocytes / drug effects
  • Adipocytes / metabolism*
  • Adipose Tissue, Brown / drug effects
  • Adipose Tissue, Brown / metabolism
  • Adipose Tissue, Brown / pathology
  • Adipose Tissue, White / drug effects
  • Adipose Tissue, White / metabolism
  • Adipose Tissue, White / pathology
  • Animals
  • Cell Differentiation / drug effects
  • Cell Proliferation / drug effects
  • Fatty Liver / complications
  • Fatty Liver / metabolism
  • Fatty Liver / pathology
  • Gene Deletion*
  • Glucose Intolerance / complications
  • Glucose Intolerance / metabolism
  • Glucose Intolerance / pathology
  • Hyperglycemia / complications
  • Hyperglycemia / metabolism
  • Hyperglycemia / pathology
  • Insulin / metabolism
  • Insulin Resistance
  • Insulin-Secreting Cells / drug effects
  • Insulin-Secreting Cells / metabolism
  • Insulin-Secreting Cells / pathology
  • Leptin / pharmacology
  • Lipodystrophy / complications
  • Lipodystrophy / metabolism
  • Lipodystrophy / pathology
  • Metabolic Syndrome / complications
  • Metabolic Syndrome / metabolism*
  • Mice
  • Organ Specificity / drug effects
  • Receptor, IGF Type 1 / metabolism
  • Receptor, Insulin / metabolism*
  • Regeneration / drug effects
  • Tamoxifen / pharmacology

Substances

  • Insulin
  • Leptin
  • Tamoxifen
  • Receptor, IGF Type 1
  • Receptor, Insulin